Helen Moore, PhD

Dr. Helen Moore graduated from the North Carolina School of Science and Mathematics and the University of North Carolina at Chapel Hill. She received her PhD in mathematics in 1995 from Stony Brook University. Her original work in differential geometry focused on shapes that minimize volume under constraints. While in academia, she won two teaching awards and received a National Science Foundation grant for her research. She was on the faculty at Bowdoin College and Stanford University, and also worked at a research mathematics institute. At Stanford, Dr. Moore collaborated with medical school faculty, shifting her use of optimization techniques to apply them to therapies for cancer, HIV, and hepatitis C.

From 2006-2021, Dr. Moore worked in the biopharma industry, including Genentech, Certara, Bristol-Myers Squibb, AstraZeneca, and Applied BioMath. Dr. Moore was selected as a Fellow of the Society for Industrial and Applied Mathematics in 2018, with the following citation: “For impactful industrial application of mathematical modeling in oncology, immunology, and virology. For mentoring, teaching, and leadership.”

Dr. Moore returned to academia in 2021, joining the Laboratory for Systems Medicine in the College of Medicine at the University of Florida. She currently has three main areas of research: modeling disease-immune dynamics, assessing systems model predictions, and optimizing combination drug regimens. She was named a Fellow of the International Society of Pharmacometrics in 2025.